LFG
RGNX icon

Larson Financial Group’s Regenxbio RGNX Stock Holding History

Larson Financial Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8
Closed -$115 – 3769
2025
Q4 		$115 Hold
8
– – ﹤0.01% 3326
2025
Q3 		$77 Buy
+8
New +$71 ﹤0.01% 3338
2025
Q2 		– Sell
-4
Closed -$29 – 3466
2025
Q1 		$29 Hold
4
– – ﹤0.01% 3026
2024
Q4 		$31 Hold
4
– – ﹤0.01% 2737
2024
Q3 		$42 Hold
4
– – ﹤0.01% 2646
2024
Q2 		$47 Buy
+4
New +$62 ﹤0.01% 2374

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Larson Financial Group's RGNX Position: Q1 2026 in Review

Larson Financial Group sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 8 shares — an estimated $115 sold.

Larson Financial Group first reported a position in RGNX in Q2 2024 and held it in 6 quarters. The position peaked at $115 in Q4 2025. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Larson Financial Group reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
  • Larson Financial Group sold 8 Regenxbio shares in Q1 2026, an estimated $115.
  • Larson Financial Group first reported a position in Regenxbio in Q2 2024 and held it in 6 quarters.
  • Larson Financial Group's Regenxbio position peaked at $115 in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.